Insider Trading History of Daniell Richard

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Daniell Richard since 2018. This trader's CIK number is 1726096. At the time of last reporting, Daniell Richard was the Exec. VP, European Commercial of Teva Pharmaceutical Industries Ltd. (stock ticker symbol TEVA). Also see all insider trading activities at Teva Pharmaceutical Industries Ltd.



Yearly summary of insider trading at Teva Pharmaceutical Industries Ltd (TEVA) by Daniell Richard

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 TEVA 0 $0 273,583 $4,345,662 321,968 $0
2024 TEVA 0 $0 168,171 $2,638,813 98,401 $0
2023 TEVA 0 $0 160,513 $1,562,992 213,689 $0
2022 TEVA 0 $0 92,685 $725,242 115,587 $0
2021 TEVA 0 $0 97,526 $1,184,224 51,754 $0
2020 TEVA 0 $0 8,139 $94,956 17,228 $0
2019 TEVA 0 $0 5,619 $79,808 7,295 $0
2018 TEVA 0 $0 6,303 $132,221 7,293 $0


Insider trading of Teva Pharmaceutical Industries Ltd (TEVA) by Daniell Richard

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-05 TEVA Option Ex 22,576 .00 0
2025-03-05 TEVA Sale 70,961 15.91 1,128,776
2025-03-04 TEVA Option Ex 237,142 .00 0
2025-03-04 TEVA Sale 91,608 15.73 1,441,451
2025-03-05 TEVA Sale 48,764 15.91 775,981
2025-03-03 TEVA Option Ex 62,250 .00 0
2025-03-03 TEVA Sale 49,314 16.19 798,196
2025-03-04 TEVA Sale 12,936 15.56 201,258
2024-08-12 TEVA Sale 98,943 17.30 1,711,417
2024-03-05 TEVA Option Ex 77,802 .00 0
2024-03-05 TEVA Sale 48,629 13.52 657,220
2024-02-28 TEVA Option Ex 20,599 .00 0
2024-02-28 TEVA Sale 20,599 13.12 270,176
2023-03-06 TEVA Sale 18,002 9.93 178,777
2023-03-07 TEVA Sale 54,007 9.43 509,177
2023-03-05 TEVA Option Ex 22,576 .00 0
2023-03-04 TEVA Option Ex 49,433 .00 0
2023-02-28 TEVA Option Ex 70,840 .00 0
2023-02-28 TEVA Sale 44,252 9.89 437,519
2023-02-28 TEVA Option Ex 70,840 .00 0
2023-02-28 TEVA Sale 44,252 9.89 437,519
2022-03-07 TEVA Sale 22,576 7.37 166,317
2022-03-04 TEVA Sale 36,376 7.48 272,201
2022-03-05 TEVA Option Ex 22,576 .00 0
2022-03-04 TEVA Option Ex 59,278 .00 0
2022-02-28 TEVA Option Ex 20,598 .00 0
2022-02-28 TEVA Sale 20,598 8.14 167,708
2022-02-09 TEVA Option Ex 13,135 .00 0
2022-02-09 TEVA Sale 13,135 9.06 119,016
2021-03-04 TEVA Option Ex 15,920 .00 0
2021-03-04 TEVA Sale 7,513 10.58 79,517
2021-03-03 TEVA Option Ex 2,101 .00 0
2021-03-03 TEVA Sale 993 10.88 10,803
2021-03-01 TEVA Sale 20,598 10.85 223,508
2021-02-28 TEVA Option Ex 20,598 .00 0
2021-02-09 TEVA Option Ex 13,135 .00 0
2021-02-09 TEVA Sale 68,422 12.72 870,396
2020-09-09 TEVA Option Ex 698 .00 0
2020-09-09 TEVA Sale 333 8.98 2,991
2020-03-17 TEVA Sale 616 7.17 4,417
2020-03-17 TEVA Option Ex 1,297 .00 0
2020-03-03 TEVA Option Ex 2,098 .00 0
2020-03-03 TEVA Sale 991 11.77 11,660
2020-02-09 TEVA Option Ex 13,135 .00 0
2020-02-10 TEVA Sale 6,199 12.24 75,888
2019-09-18 TEVA Option Ex 2,489 .00 0
2019-09-18 TEVA Sale 1,176 7.82 9,196
2019-09-09 TEVA Sale 333 7.16 2,384
2019-09-09 TEVA Option Ex 696 .00 0
2019-03-17 TEVA Option Ex 1,297 .00 0
2019-03-18 TEVA Sale 1,297 16.64 21,588
2019-03-12 TEVA Sale 715 15.69 11,218
2019-03-12 TEVA Option Ex 715 .00 0
2019-03-03 TEVA Option Ex 2,098 .00 0
2019-03-04 TEVA Sale 2,098 16.88 35,422
2018-09-18 TEVA Sale 2,488 23.69 58,943
2018-09-18 TEVA Option Ex 2,488 .00 0
2018-09-09 TEVA Option Ex 696 .00 0
2018-09-10 TEVA Sale 696 21.25 14,790
2018-03-17 TEVA Option Ex 1,297 .00 0
2018-03-19 TEVA Sale 1,297 17.89 23,205
2018-03-12 TEVA Option Ex 714 .00 0
2018-03-12 TEVA Sale 714 19.50 13,921
2018-03-03 TEVA Option Ex 2,098 .00 0
2018-03-05 TEVA Sale 1,108 19.28 21,362

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Daniell Richard (Exec. VP, European Commercial of Teva Pharmaceutical Industries Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.